Escitalopram-Induced Amenorrhea and False Positive Urine Pregnancy Test.
10.4082/kjfm.2017.38.1.40
- Author:
Vithyalakshmi SELVARAJ
1
;
Siv HOUR
;
Palanikumar GUNASEKAR
;
Caron GRAY
;
James F SMITH
Author Information
1. Department of Psychiatry, Creighton University School of Medicine, Omaha, USA. vidyaselvaraj@creighton.edu
- Publication Type:Case Report
- Keywords:
Selective Serotonin Reuptake Inhibitors;
Hyperprolactinemia;
Amenorrhea;
Immunologic Pregnancy Tests;
Case Reports
- MeSH:
Adult;
Amenorrhea*;
Anxiety Disorders;
Citalopram;
Depressive Disorder, Major;
Female;
Humans;
Hyperprolactinemia;
Pregnancy;
Pregnancy Tests*;
Pregnancy Tests, Immunologic;
Pregnancy*;
Serotonin;
Serotonin Uptake Inhibitors;
United States Food and Drug Administration
- From:Korean Journal of Family Medicine
2017;38(1):40-42
- CountryRepublic of Korea
- Language:English
-
Abstract:
Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.
